Benzinga's Top Downgrades

Loading...
Loading...

 

  • Analysts at JP Morgan downgraded Esperion Therapeutics Inc ESPR from Overweight to Neutral. The price target for Esperion Therapeutics has been lowered from $50 to $15. Esperion Therapeutics shares fell 32.51 percent to $10.92 in pre-market trading.
  • Analysts at Wells Fargo downgraded HeartWare International Inc HTWR from Outperform to Market Perform. Heartware shares closed at $57.55 on Tuesday.
  • Goldman Sachs downgraded PBF Energy Inc PBF from Buy to Neutral. The price target for PBF Energy has been lowered from $37 to $26. PBF Energy shares slipped 0.04 percent to $23.28 in pre-market trading.
  • Analysts at Bank of America downgraded Lincoln National Corporation LNC from Buy to Neutral. Lincoln National shares rose 0.33 percent to $36.89 in pre-market trading.
  • Susquehanna downgraded COMSCORE, Inc. SCOR from Positive to Neutral. comScore shares closed at $23.83 on Tuesday.
  • Evercore ISI Group downgraded Oceaneering International OII from Buy to Hold. Oceaneering International shares closed at $28.62 on Tuesday.
  • RBC Capital downgraded Metaldyne Performance Group Inc MPG from Outperform to Sector Perform. Metaldyne Performance Group shares closed at $13.62 on Tuesday.
  • Bank of America downgraded Principal Financial Group Inc PFG from Buy to Neutral. Principal Financial shares gained 0.10 percent to $39.10 in pre-market trading.
  • Analysts at Barclays downgraded AEGON N.V. (ADR) AEG from Equal-weight to Underweight. Aegon shares fell 1.98 percent to $3.96 in pre-market trading.
Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsFinancialsLife & Health InsuranceTop Downgrades
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...